Alnylam Pharmaceuticals, Inc.

SBI Okasan Asset Management Co.Ltd. ALNY
Report date
3/31/2026
Quarter
2026 Q1
Filed
4/27/2026
Shares
3,100
Value ($000)
980
Weight
0.0%
2025 Q4 - 2026 Q1 (2 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).